Hepatitis B surface antigen (HBsAg) prevalence (%) in Lithuania
Lithuania: Hepatitis B surface antigen (HBsAg) prevalence was 0.1% in 2024. ▬ Flat
Latest (2024)
0.1%
Change on year
unchanged
World rank
101st
of 194 countries
All-time high
0.1%
in 2015
All-time low
0.1%
in 2015
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Lithuania, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, hepatitis b surface antigen (hbsag) prevalence in Lithuania stood at 0.1%. That is the highest value across all 10 years on record.
Compared with earlier readings it is unchanged over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Lithuania peaked at 0.1% in 2015 and was at its lowest, 0.1%, in 2015.
That places Lithuania 101st out of 194 countries with data for 2024, putting it in the middle of the range.
Hepatitis B surface antigen (HBsAg) prevalence in Lithuania, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.1% | — |
| 2016 | 0.1% | +0.0% |
| 2017 | 0.1% | +0.0% |
| 2018 | 0.1% | +0.0% |
| 2019 | 0.1% | +0.0% |
| 2020 | 0.1% | +0.0% |
| 2021 | 0.1% | +0.0% |
| 2022 | 0.1% | +0.0% |
| 2023 | 0.1% | +0.0% |
| 2024 | 0.1% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.1% | 5 |
| 2020s | 0.1% | 0.1% | 0.1% | 5 |
Countries ranked near Lithuania
- 101 Singapore 0.1% compare
- 101 Serbia 0.1% compare
- 101 Thailand 0.1% compare
- 101 Trinidad and Tobago 0.1% compare
- 101 Tunisia 0.1% compare
- 101 Ukraine 0.1% compare
- 101 Uzbekistan 0.1% compare
- 101 Albania 0.1% compare
- 101 Armenia 0.1% compare
- 101 Australia 0.1% compare
- 101 Belize 0.1% compare
- 101 Bolivia 0.1% compare
- 101 Bhutan 0.1% compare
- 101 China 0.1% compare
- 101 Denmark 0.1% compare
- 101 Dominican Republic 0.1% compare
- 101 Algeria 0.1% compare
- 101 Gambia 0.1% compare
- 101 Guyana 0.1% compare
- 101 Hungary 0.1% compare
- 101 Israel 0.1% compare
- 101 Jordan 0.1% compare
- 101 Kyrgyzstan 0.1% compare
- 101 Lebanon 0.1% compare
- 101 Malaysia 0.1% compare
- 101 Oman 0.1% compare
- 101 Peru 0.1% compare
- 101 Paraguay 0.1% compare
- 101 Romania 0.1% compare
- 101 Russia 0.1% compare
More health data for Lithuania
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.4537 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,909 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -4.51 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0199 units per person (2025)
- Population ages 00-04, male, annual growth rate -4.59 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Lithuania?
- Hepatitis b surface antigen (hbsag) prevalence in Lithuania was 0.1% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Lithuania?
- The highest recorded value was 0.1% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Lithuania?
- The lowest recorded value was 0.1% in 2015.
- How does Lithuania rank for hepatitis b surface antigen (hbsag) prevalence?
- Lithuania ranks 101st out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Lithuania?
- Over the last ten years it is unchanged. The long-run trend across the full record is flat.
- Where does this Lithuania data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).